Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1999
11/16/1999US5985296 Complexes of gamma-cyclodextrin and retinol or retinol derivatives, processes for their preparation and their use
11/16/1999US5985281 Antibody directed enzyme prodrug therapy (adept) using a non-naturally occuring mutant form of a host enzyme, especially a mutant form of ribonuclease.
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999US5985263 Substantially pure histidine-linked protein polymer conjugates
11/16/1999US5985255 Fluid composition containing a wax microdispersion and a cationic surfactant, a method for its preparation and uses thereof
11/16/1999US5985248 Preparing dry powders having hydrophobic and hydrophilic components
11/16/1999US5985246 Contrast agents for ultrasonic imaging and methods for preparing the same
11/16/1999CA2078118C Cc-1065 analogs
11/16/1999CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates
11/16/1999CA1340820C Absorbant precipitated silica and composition containing said silica
11/11/1999WO1999057217A1 Environmentally preferred fluids and fluid blends
11/11/1999WO1999057151A2 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
11/11/1999WO1999057094A2 Perfluorinated esters of alkanoyl l-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds
11/11/1999WO1999056792A1 Positron emission tomography using gallium-68 chelates
11/11/1999WO1999056783A1 Hydrogel for the therapeutic treatment of aneurysms
11/11/1999WO1999056782A1 Adhesive microsphere drug delivery composition
11/11/1999WO1999056776A2 Adjuvant composition and methods for its use
11/11/1999WO1999056772A2 Hepatitis vaccine
11/11/1999WO1999056743A1 Oral preparations containing forskolin derivatives and process for producing medicinal preparations
11/11/1999WO1999056741A1 Methods for treating female sexual dysfunction
11/11/1999WO1999056731A1 Matrices formed of polymer and hydrophobic compounds for use in drug delivery
11/11/1999WO1999056726A1 Use of pharmaceutical compositions capable of being gelled in periodontology
11/11/1999WO1999056725A1 Pharmaceutical compositions capable of being gelled
11/11/1999WO1999056723A2 Hemoglobine-haptoglobin complexes for targeted drug delivery
11/11/1999WO1999056697A2 Pharmaceutical composition
11/11/1999WO1999048901A3 Sucrose-n-alkyl-asparaginates, production and use thereof
11/11/1999WO1999047172A3 Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
11/11/1999WO1999040214A3 Nucleic acid delivery vehicles
11/11/1999DE4244930C2 High bio:availability cyclosporin compsn. for oral admin.
11/11/1999DE19818955A1 Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat Composition containing polyacrylate, polyterpene, nitroglycerin, and optionally, polyvinyl acetate
11/11/1999CA2331617A1 Environmentally preferred fluids and fluid blends
11/11/1999CA2330863A1 Adhesive microsphere drug delivery composition
11/11/1999CA2330610A1 Adjuvant composition and methods for its use
11/11/1999CA2329736A1 Oral preparations containing forskolin derivatives and process for producing medicinal preparations
11/10/1999EP0955064A1 Process for producing drug complexes
11/10/1999EP0955063A1 Use of aqueous compositions in medicaments for subcutaneous or intramuscular administration
11/10/1999EP0955062A1 Human growth hormone aqueous formulation
11/10/1999EP0955056A1 Recombinant colony stimulating factor-1 for treatment of fungal infection
11/10/1999EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999EP0955041A2 Aqueous dispersion useful for the production of coating and binding means for oral solid medicament
11/10/1999EP0954573A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
11/10/1999EP0954537A2 Chitosan-conjugates with acidic chelate-complex forming agents
11/10/1999EP0954340A1 Targeted combination immunotherapy of cancer
11/10/1999EP0954339A2 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
11/10/1999EP0954338A2 Cationic amphiphile/dna complexes
11/10/1999EP0954337A1 Intestinal absorption of nicotine to treat nicotine responsive conditions
11/10/1999EP0954336A2 Membrane incorporation of texaphyrins
11/10/1999EP0954329A1 Method of killing target cells in harvested cell populations with one or more immunotoxins
11/10/1999EP0954315A2 Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
11/10/1999EP0954300A2 Prophylactic and therapeutic treatment of skin sensitization and irritation
11/10/1999EP0954294A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds
11/10/1999EP0954292A1 Pharmaceutical formulations with delayed drug release
11/10/1999EP0954291A1 Soluble form osmotic dose delivery system
11/10/1999EP0954290A1 Controlled-release pharmaceutical tablet containing a carrier based on cross-linked amylose and hydroxypropylmethylcellulose
11/10/1999EP0954288A1 Solid solution of an antifungal agent with enhanced bioavailability
11/10/1999EP0954287A1 Controlled release composition
11/10/1999EP0954285A1 Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
11/10/1999EP0954283A2 Formulation and method for treating neoplasms by inhalation
11/10/1999EP0954282A1 Preparation of particles for inhalation
11/10/1999EP0954278A1 Pharmaceutical compositions containing kukui nut oil
11/10/1999EP0954274A1 Topical product formulations containing strontium for reducing skin irritation
11/10/1999EP0954260A1 Compositions, methods and devices for the transdermal delivery of drugs
11/10/1999EP0748332B1 New cholesterol derivative for liposomal gene transfer
11/10/1999CN1234806A G protein-coupled receptor antagonists
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/10/1999CN1234277A Use of polymerized fatty acid derivative and emtrol derivative as solubilizer
11/10/1999CN1234230A Chewing article
11/10/1999CN1046202C Preparation method for improved freeze dried isocyclophosphamide composition
11/09/1999US5981826 Poly(vinyl alcohol) cryogel
11/09/1999US5981726 Chimeric and mutationally stabilized tumor-specific B1, B3 and B5 antibody fragments; immunotoxic fusion proteins; and uses thereof
11/09/1999US5981725 Structural alterations of the EGF receptor gene in human tumors
11/09/1999US5981719 Macromolecular microparticles and methods of production and use
11/09/1999US5981718 Polypeptide with reduced allergenicity
11/09/1999US5981709 Conjugating an acid stable alpha-interferon with an activated non-antigenic polymer in solution, acidifying solution to selectively cleave linkages that reduce bioactivity, adjust solution to a physiological ph
11/09/1999US5981605 Containing more than 90% of a drying and/or protein coagulating, short-chained alcohol or alcohol mixture, primarily ethanol, and gelling agent; good skin-adhesive properties, matrix formation, forms a protective coating
11/09/1999US5981578 Increased solubilization and stable cosmetic preparations of ascorbic acid
11/09/1999US5981568 Therapeutic inhibitor of vascular smooth muscle cells
11/09/1999US5981518 Gallium complexes of 3-hydroxy-4-pyrones to treat or prevent calcium homeostasis disorders
11/09/1999US5981507 A conjugated prodrugs for the treatment of viral infections and cancer with substantially enhanced therapeutic efficacy and reduces toxicity
11/09/1999US5981489 Nonaqueous peptide compound which consists essentially of about 30% to about 50% (w/w) of the lhrh-related compound leuprolilde acetate in polyoxyethylene glcol or mixture
11/09/1999US5981485 Contains human growth hormone, a buffer, a non-ionic surfactant, and a neutral salt free of glycine and mannitol and have improved storage stability
11/09/1999US5981474 Solubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same
11/09/1999US5981278 Immunoglobulin which binds to a peptide which is part of the an envelope protein of the acquired immunodeficiency virus; viricide; for vaccine development
11/09/1999US5981273 Composition comprising an endosomolytic agent for introducing nucleic acid complexes into higher eucaryotic cells
11/09/1999US5981259 CD4+ T-lymphocyte protease genes and inhibitors thereof
11/09/1999US5980972 Method of applying drug-release coatings
11/09/1999US5980952 Comprising rapid-release minigranules and slow-release minigranules; for delivering two concentration peaks of dexfenfluramine in the plasma to treat obesity
11/09/1999US5980948 Polyetherester copolymers as drug delivery matrices
11/09/1999US5980946 Collagen formulations
11/09/1999US5980945 Sustained release drug formulations
11/09/1999US5980941 A glycerine-free tabletable mixture comprising a saccharide carrier and the sugar alcohols sorbitol and xylitol; forming tablets
11/09/1999US5980938 Administering a dibenzyl benzopyrans
11/09/1999US5980935 A liposomal conjugated composition for enhancing delivery of nucleic acids into cells; comprising at least one nucleic acid, amino acid arginine, a linker zwitterion and a lipid dioleoylphosphatidylethanolamine or cholesterol
11/09/1999US5980933 Transdermal formulation of xanomeline
11/09/1999US5980925 A washing solution comprising an anchoring agent for improving the efficacy of a polar microbiocide agent on the skin; hand washes, wound cleansers, body washes, mouthwashes, surgical scrubs
11/09/1999US5980918 A wound and burns healing mixture in creams and gels
11/09/1999US5980915 Administering an antiprotozoa agent
11/09/1999US5980896 Antibodies reactive with human carcinomas
11/09/1999US5980895 Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require proteolytic activation
11/09/1999US5980883 Polymer gel for medical use
1 ... 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 ... 1712